See more : QL Resources Berhad (7084.KL) Income Statement Analysis – Financial Results
Complete financial analysis of Abbott India Limited (ABBOTINDIA.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Abbott India Limited, a leading company in the Drug Manufacturers – General industry within the Healthcare sector.
You may be interested
- Kukdo Chemical Co., Ltd. (007690.KS) Income Statement Analysis – Financial Results
- LY Corporation (4689.T) Income Statement Analysis – Financial Results
- AS PARTNERS CO LTD (160A.T) Income Statement Analysis – Financial Results
- Tonlin Department Store Co.,Ltd. (2910.TW) Income Statement Analysis – Financial Results
- Central Glass Co., Ltd. (4044.T) Income Statement Analysis – Financial Results
Abbott India Limited (ABBOTINDIA.NS)
About Abbott India Limited
Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolic, central nervous system, pain management, pre-term labor, vitamins, insomnia, vaccines, consumer health, etc. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. Abbott India Limited was incorporated in 1944 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 58.49B | 53.49B | 49.10B | 43.08B | 40.91B | 36.76B | 33.00B | 28.86B | 25.78B | 22.35B | 18.69B | 16.10B | 14.46B | 9.90B | 7.61B | 6.66B | 5.94B | 5.10B | 4.45B | 4.05B |
| Cost of Revenue | 39.03B | 29.75B | 26.57B | 23.91B | 23.16B | 20.89B | 19.05B | 17.12B | 15.08B | 13.12B | 10.88B | 9.72B | 8.59B | 6.47B | 5.04B | 4.55B | 4.08B | 3.53B | 2.96B | 2.49B |
| Gross Profit | 19.46B | 23.74B | 22.53B | 19.17B | 17.76B | 15.87B | 13.96B | 11.74B | 10.70B | 9.23B | 7.82B | 6.38B | 5.87B | 3.43B | 2.57B | 2.11B | 1.86B | 1.57B | 1.49B | 1.56B |
| Gross Profit Ratio | 33.27% | 44.38% | 45.88% | 44.50% | 43.40% | 43.18% | 42.29% | 40.68% | 41.51% | 41.30% | 41.82% | 39.64% | 40.58% | 34.61% | 33.74% | 31.71% | 31.27% | 30.75% | 33.49% | 38.53% |
| Research & Development | 9.60M | 7.90M | 8.10M | 8.40M | 6.90M | 6.73M | 687.10K | 7.57M | 7.06M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.27B | 1.32B | 1.58B | 1.34B | 814.59M | 890.99M | 757.87M | 800.88M | 720.36M | 499.00M | 622.88M | 312.83M | 874.30M | 145.80M | 420.56M | 385.70M | 290.30M | 223.30M | 195.00M | 203.00M |
| Selling & Marketing | 2.10B | 2.18B | 2.50B | 2.00B | 2.22B | 1.91B | 1.57B | 1.48B | 1.52B | 1.36B | 1.31B | 1.05B | 998.90M | 672.13M | 547.51M | 478.20M | 398.40M | 348.50M | 281.10M | 263.40M |
| SG&A | 3.37B | 3.50B | 4.08B | 3.34B | 3.04B | 2.80B | 2.33B | 2.28B | 2.24B | 1.85B | 5.54B | 1.36B | 1.87B | 817.92M | 968.07M | 863.90M | 688.70M | 571.80M | 476.10M | 466.40M |
| Other Expenses | 2.48B | 8.88B | 8.18B | 7.11B | 7.67B | 20.55M | 2.86M | 3.91M | 4.91B | 4.32B | 0.00 | 3.00M | -512.46M | 1.72B | 479.77M | 366.50M | 172.20M | 128.10M | 142.60M | -287.90M |
| Operating Expenses | 5.99B | 12.38B | 12.27B | 10.45B | 10.70B | 9.96B | 8.81B | 7.90B | 7.15B | 6.17B | 5.70B | 4.69B | 3.85B | 2.54B | 1.45B | 1.23B | 860.90M | 699.90M | 618.70M | 178.50M |
| Cost & Expenses | 44.43B | 42.13B | 38.84B | 34.36B | 33.86B | 30.84B | 27.86B | 25.02B | 22.23B | 19.29B | 16.57B | 14.41B | 12.44B | 9.01B | 6.49B | 5.78B | 4.95B | 4.23B | 3.58B | 2.67B |
| Interest Income | 2.24B | 1.44B | 760.60M | 797.20M | 1.13B | 1.01B | 713.98M | 576.43M | 504.42M | 435.99M | 352.34M | 218.54M | 184.31M | 68.69M | 58.16M | 64.10M | 500.00K | 5.90M | 1.10M | 1.50M |
| Interest Expense | 124.50M | 159.90M | 191.00M | 182.80M | 85.32M | 22.48M | 38.22M | 20.37M | 8.05M | 5.03M | 0.00 | 239.00K | 300.00K | 161.00K | 2.03M | 200.00K | 200.00K | 1.20M | 200.00K | 1.70M |
| Depreciation & Amortization | 711.70M | 699.70M | 661.00M | 570.50M | 596.09M | 169.21M | 161.85M | 164.31M | 144.41M | 149.42M | 166.36M | 194.87M | 149.95M | 112.50M | 90.14M | 69.80M | 56.60M | 44.40M | 39.90M | 41.70M |
| EBITDA | 16.98B | 13.56B | 11.61B | 9.98B | 8.71B | 7.16B | 6.38B | 4.53B | 4.12B | 3.59B | 2.56B | 2.34B | 1.95B | 1.05B | 1.26B | 995.80M | 1.06B | 908.80M | 898.20M | 1.42B |
| EBITDA Ratio | 29.03% | 25.42% | 23.74% | 23.39% | 21.29% | 19.25% | 18.09% | 15.73% | 16.17% | 16.10% | 12.40% | 12.94% | 13.79% | 10.77% | 16.67% | 15.24% | 17.74% | 18.02% | 20.50% | 35.19% |
| Operating Income | 14.06B | 12.90B | 11.00B | 9.49B | 8.11B | 5.91B | 5.14B | 3.84B | 3.55B | 3.06B | 2.15B | 1.69B | 2.02B | 888.04M | 1.12B | 880.50M | 997.50M | 869.20M | 870.40M | 1.38B |
| Operating Income Ratio | 24.03% | 24.11% | 22.39% | 22.04% | 19.83% | 16.09% | 15.58% | 13.31% | 13.78% | 13.68% | 11.51% | 10.50% | 13.96% | 8.97% | 14.72% | 13.23% | 16.78% | 17.04% | 19.57% | 34.12% |
| Total Other Income/Expenses | 2.12B | 1.27B | 538.10M | -233.80M | -87.29M | 1.08B | 1.07B | 518.59M | 452.66M | 386.52M | 322.84M | 460.11M | -217.10M | -45.70M | 50.42M | 63.00M | 8.10M | 5.20M | 700.00K | -7.60M |
| Income Before Tax | 16.18B | 12.74B | 10.80B | 9.26B | 8.03B | 6.99B | 6.21B | 4.36B | 4.02B | 3.44B | 2.48B | 2.15B | 1.80B | 941.45M | 1.17B | 943.50M | 1.02B | 874.40M | 871.10M | 1.37B |
| Income Before Tax Ratio | 27.66% | 23.82% | 21.99% | 21.49% | 19.62% | 19.01% | 18.83% | 15.12% | 15.58% | 15.41% | 13.24% | 13.36% | 12.46% | 9.51% | 15.43% | 14.17% | 17.14% | 17.14% | 19.59% | 33.93% |
| Income Tax Expense | 4.17B | 3.24B | 2.81B | 2.35B | 2.10B | 2.49B | 2.20B | 1.60B | 1.42B | 1.15B | 807.63M | 702.92M | 597.65M | 332.10M | 394.85M | 324.90M | 334.30M | 274.50M | 279.40M | 352.00M |
| Net Income | 12.01B | 9.49B | 7.99B | 6.91B | 5.93B | 4.50B | 4.01B | 2.77B | 2.60B | 2.29B | 1.67B | 1.45B | 1.20B | 609.35M | 775.10M | 628.70M | 684.30M | 598.60M | 591.70M | 1.02B |
| Net Income Ratio | 20.54% | 17.75% | 16.27% | 16.03% | 14.49% | 12.25% | 12.16% | 9.59% | 10.07% | 10.24% | 8.92% | 8.99% | 8.33% | 6.16% | 10.19% | 9.44% | 11.51% | 11.73% | 13.31% | 25.24% |
| EPS | 565.30 | 446.80 | 375.87 | 325.04 | 279.04 | 211.93 | 188.81 | 130.19 | 120.12 | 107.75 | 78.47 | 68.10 | 56.66 | 44.56 | 56.68 | 43.62 | 46.01 | 39.18 | 38.72 | 66.92 |
| EPS Diluted | 565.30 | 446.80 | 375.87 | 325.04 | 279.04 | 211.93 | 188.81 | 130.19 | 120.12 | 107.75 | 78.47 | 68.10 | 56.66 | 44.56 | 56.68 | 43.62 | 46.01 | 39.18 | 38.72 | 66.92 |
| Weighted Avg Shares Out | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M |
| Weighted Avg Shares Out (Dil) | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M | 21.25M |
No news found for: ABBOTINDIA.NS
Source: https://incomestatements.info
Category: Stock Reports